Amedisys Pays $44M To End Investors' Medicare Fraud Suit

By Cara Mannion · June 16, 2017, 7:38 PM EDT

Amedisys Inc. has agreed to pay $43.75 million to settle a shareholder suit alleging the health care provider and its top executives hid a Medicare fraud scheme that caused its stock...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Bach et al v. Amedisys, Inc. et al

Case Number

3:10-cv-00395

Court

Louisiana Middle

Nature of Suit

Securities/Commodities

Date Filed

June 10, 2010